These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 34010787)
21. ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia. Henze G; v Stackelberg A; Eckert C Klin Padiatr; 2013 May; 225 Suppl 1():S73-8. PubMed ID: 23700062 [TBL] [Abstract][Full Text] [Related]
22. Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation. Chen Y; Cheng Y; Suo P; Yan C; Wang Y; Chen Y; Han W; Xu L; Zhang X; Liu K; Chang L; Xiao L; Huang X Br J Haematol; 2017 Nov; 179(4):598-605. PubMed ID: 29076142 [TBL] [Abstract][Full Text] [Related]
23. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. Dopfer R; Henze G; Bender-Götze C; Ebell W; Ehninger G; Friedrich W; Gadner H; Klingebiel T; Peters C; Riehm H Blood; 1991 Nov; 78(10):2780-4. PubMed ID: 1824271 [TBL] [Abstract][Full Text] [Related]
24. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013. Olsson L; Ivanov Öfverholm I; Norén-Nyström U; Zachariadis V; Nordlund J; Sjögren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B Br J Haematol; 2015 Sep; 170(6):847-58. PubMed ID: 26018335 [TBL] [Abstract][Full Text] [Related]
25. Relapsed or Refractory Lymphoblastic Lymphoma in Children: Results and Analysis of 23 Patients in the EORTC 58951 and the LMT96 Protocols. Michaux K; Bergeron C; Gandemer V; Mechinaud F; Uyttebroeck A; Bertrand Y; Pediatr Blood Cancer; 2016 Jul; 63(7):1214-21. PubMed ID: 27037853 [TBL] [Abstract][Full Text] [Related]
26. Minimal residual disease level determined by flow cytometry provides reliable risk stratification in adults with T-cell acute lymphoblastic leukaemia. Wang H; Zhou Y; Huang X; Zhang Y; Qian J; Li J; Li C; Li X; Lou Y; Zhu Q; Huang Y; Meng H; Yu W; Tong H; Jin J; Zhu HH Br J Haematol; 2021 Jun; 193(6):1096-1104. PubMed ID: 33764511 [TBL] [Abstract][Full Text] [Related]
27. Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment. Zugmaier G; Gökbuget N; Klinger M; Viardot A; Stelljes M; Neumann S; Horst HA; Marks R; Faul C; Diedrich H; Reichle A; Brüggemann M; Holland C; Schmidt M; Einsele H; Bargou RC; Topp MS Blood; 2015 Dec; 126(24):2578-84. PubMed ID: 26480933 [TBL] [Abstract][Full Text] [Related]
28. Superior survival of unmanipulated haploidentical haematopoietic stem cell transplantation compared with intensive chemotherapy as post-remission treatment for children with very high-risk philadelphia chromosome negative B-cell acute lymphoblastic leukaemia in first complete remission. Xue YJ; Suo P; Huang XJ; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Kong J; Zhang XH; Chen YH; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Cheng YF Br J Haematol; 2020 Mar; 188(5):757-767. PubMed ID: 31725190 [TBL] [Abstract][Full Text] [Related]
29. Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t(v;11q23)/MLL-rearranged B-cell acute lymphoblastic leukemia. Bai L; Cheng YF; Lu AD; Suo P; Wang Y; Zuo YX; Yan CH; Wu J; Jia YP; Sun YQ; Chen YH; Chen H; Liu KY; Han W; Xu LP; Wang JB; Tang XF; Chen HR; Zhang LP; Huang XJ Leuk Res; 2020 Apr; 91():106333. PubMed ID: 32109757 [TBL] [Abstract][Full Text] [Related]
30. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol. Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691 [TBL] [Abstract][Full Text] [Related]
31. Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Jabbour E; Short NJ; Jorgensen JL; Yilmaz M; Ravandi F; Wang SA; Thomas DA; Khoury J; Champlin RE; Khouri I; Kebriaei P; O'Brien SM; Garcia-Manero G; Cortes JE; Sasaki K; Dinardo CD; Kadia TM; Jain N; Konopleva M; Garris R; Kantarjian HM Cancer; 2017 Jan; 123(2):294-302. PubMed ID: 27602508 [TBL] [Abstract][Full Text] [Related]
32. Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials. Barba P; Morgades M; Montesinos P; Gil C; Fox ML; Ciudad J; Moreno MJ; González-Campos J; Genescà E; Martínez-Carballeira D; Martino R; Vives S; Guardia R; Mercadal S; Artola MT; Cladera A; Tormo M; Esteve J; Bergua J; Vall-Llovera F; Ribera J; Martínez-Sanchez P; Amigo ML; Bermúdez A; Calbacho M; Hernández-Rivas JM; Feliu E; Orfao A; Ribera JM Eur J Haematol; 2019 Jan; 102(1):79-86. PubMed ID: 30267597 [TBL] [Abstract][Full Text] [Related]
33. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial. Vora A; Goulden N; Mitchell C; Hancock J; Hough R; Rowntree C; Moorman AV; Wade R Lancet Oncol; 2014 Jul; 15(8):809-18. PubMed ID: 24924991 [TBL] [Abstract][Full Text] [Related]
34. Management of patients with acute lymphoblastic leukemia in routine clinical practice: Minimal residual disease testing, treatment patterns and clinical outcomes in Belgium, Greece and Switzerland. Deeren D; Balabanov S; Nickel K; Giannopoulou C; Gonzalez-McQuire S; Kutikova L; Bouwmeester W; Spyridonidis A Leuk Res; 2020 Apr; 91():106334. PubMed ID: 32135394 [TBL] [Abstract][Full Text] [Related]
35. Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes. Brammer JE; Saliba RM; Jorgensen JL; Ledesma C; Gaballa S; Poon M; Maziarz RT; Champlin RE; Hosing C; Kebriaei P Bone Marrow Transplant; 2017 Jan; 52(1):20-27. PubMed ID: 27618682 [TBL] [Abstract][Full Text] [Related]
36. Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-PBX1 treated with measurable residual disease-oriented protocols. Ribera J; Granada I; Morgades M; González T; Ciudad J; Such E; Calasanz MJ; Mercadal S; Coll R; González-Campos J; Tormo M; García-Cadenas I; Gil C; Cervera M; Barba P; Costa D; Ayala R; Bermúdez A; Orfao A; Ribera JM; Br J Haematol; 2022 Feb; 196(3):670-675. PubMed ID: 34549416 [TBL] [Abstract][Full Text] [Related]
38. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol]. Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062 [No Abstract] [Full Text] [Related]
39. Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia. Sutton R; Shaw PJ; Venn NC; Law T; Dissanayake A; Kilo T; Haber M; Norris MD; Fraser C; Alvaro F; Revesz T; Trahair TN; Dalla-Pozza L; Marshall GM; O'Brien TA Br J Haematol; 2015 Feb; 168(3):395-404. PubMed ID: 25312094 [TBL] [Abstract][Full Text] [Related]
40. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol]. Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]